Sara van den Berg

220 Chapter 8 41. Goodier, M.R., et al., CMV and natural killer cells: shaping the response to vaccination. Eur J Immunol, 2018. 48(1): p. 50-65. 42. Derhovanessian, E., et al., Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol, 2011. 92(Pt 12): p. 2746-56. 43. Wallace, D.L., et al., Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects. Immunology, 2011. 132(1): p. 27-38. 44. Vescovini, R., et al., Impact of Persistent Cytomegalovirus Infection on Dynamic Changes in Human Immune System Profile. PLoS One, 2016. 11(3): p. e0151965. 45. Abana, C.O., et al., Cytomegalovirus (CMV) Epitope-Specific CD4(+) T-cells Are Inflated in HIV(+) CMV(+) Subjects. J Immunol, 2017. 199(9): p. 3187-3201. 46. Jackson, S.E., et al., Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus- specific CD8+ T-cells. J Virol, 2014. 88(18): p. 10894-908. 47. Hosie, L., et al., Cytomegalovirus-Specific T-cells Restricted by HLA-Cw*0702 Increase Markedly with Age and Dominate the CD8(+) T-Cell Repertoire in Older People. Front Immunol, 2017. 8: p. 1776. 48. Gamadia, L.E., et al., Primary immune responses to human CMV: a critical role for IFN-gamma- producing CD4+ T-cells in protection against CMV disease. Blood, 2003. 101(7): p. 2686-92. 49. Hertoghs, K.M., et al., Molecular profiling of cytomegalovirus-induced human CD8+ T-cell differentiation. J Clin Invest, 2010. 120(11): p. 4077-90. 50. Jackson, S.E., et al., Generation, maintenance and tissue distribution of T-cell responses to human cytomegalovirus in lytic and latent infection. Med Microbiol Immunol, 2019. 51. Kahan, S.M., E.J. Wherry, and A.J. Zajac, T-cell exhaustion during persistent viral infections. Virology, 2015. 479-480: p. 180-93. 52. Nikolich-Zugich, J., et al., Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging. Geroscience, 2020. 42(2): p. 495-504. 53. Nikolich-Zugich, J. and R.A.W. van Lier, Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence. Geroscience, 2017. 54. Gkrania-Klotsas, E., et al., Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis, 2012. 206(12): p. 1897-903. 55. Lebedeva, A.M., et al., Cytomegalovirus Infection in Cardiovascular Diseases. Biochemistry (Mosc), 2018. 83(12): p. 1437-1447. 56. Mathei, C., et al., Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J Am Geriatr Soc, 2011. 59(12): p. 2201-8. 57. Alonso Arias, R., et al., Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol, 2013. 87(8): p. 4486-95. 58. Araujo Carvalho, A.C., et al., Association between human herpes virus seropositivity and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev, 2018. 48: p. 145-152. 59. Vescovini, R., et al., Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol, 2010. 184(6): p. 3242-9.